LILRB4; ILT3; LIR5; Leukocyte immunoglobulin-like receptor subfamily B member 4; CD85 antigen-like family member K; Immunoglobulin-like transcript 3; ILT-3; Leukocyte immunoglobulin-like receptor 5; L
Application:
IF,ELISA
Reactivity:
Human
Immunogen:
The antiserum was produced against synthesized peptide derived from human LILRB4. AA range:201-250
Formulation:
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Source:
Rabbit
Dilution:
Immunofluorescence: 1/200 - 1/1000. ELISA: 1/20000. Not yet tested in other applications.
Other NameLILRB4; ILT3; LIR5; Leukocyte immunoglobulin-like receptor subfamily B member 4; CD85 antigen-like family member K; Immunoglobulin-like transcript 3; ILT-3; Leukocyte immunoglobulin-like receptor 5; L
ApplicationIF,ELISA
ReactivityHuman
ImmunogenThe antiserum was produced against synthesized peptide derived from human LILRB4. AA range:201-250
FormulationLiquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
SourceRabbit
DilutionImmunofluorescence: 1/200 - 1/1000. ELISA: 1/20000. Not yet tested in other applications.